Chenhui Wang

Chenhui Wang

Auto-generated profile, based on publicly available information

Chenhui Wang

Bioinformatics Center of AMMS, Beijing 100850, China

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2020 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
BDBo Diao
Bo Diao
CWChenhui Wang
Chenhui Wang
YTYingjun Tan
Yingjun Tan
XCXiewan Chen
Xiewan Chen
YLYing Liu
Ying Liu
YCYongwen Chen
Yongwen Chen
Background: The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed great threat to human health. T cells play a critical role in antiviral immunity but their numbers and functional state in COVID-19 patients remain largely unclear. Methods: We retrospectively reviewed the counts of T cells and serum cytokine concentration from data of 522 patients with laboratory-confirmed COVID-19 and 40 healthy controls. In addition, the expression of T cell exhaustion markers were measured in 14 COVID-19 cases. Results: The number of total T cells, CD4+ and CD8+ T cells were dramatically reduced in COVID-19 patients, especially in patients requiring Intensive Care Unit (ICU) care. Counts of total T cells, CD8+ T cells or CD4+ T cells lower than 800, 300, or 400/μL, respectively, were negatively correlated with patient survival. T cell numbers were negatively correlated to serum IL-6, IL-10, and TNF-α concentration, with patients in the disease resolution period showing reduced IL-6, IL-10, and TNF-α concentrations and restored T cell counts. T cells from COVID-19 patients had significantly higher levels of the exhausted marker PD-1. Increasing PD-1 and Tim-3 expression on T cells was seen as patients progressed from prodromal to overtly symptomatic stages. Conclusions: T cell counts are reduced significantly in COVID-19 patients, and the surviving T cells appear functionally exhausted. Non-ICU patients with total T cells counts lower than 800/μL may still require urgent intervention, even in the immediate absence of more severe symptoms due to a high risk for further deterioration in condition.

22 September 2019 in Hepatology
Verified
Journal Article
Closed access
PDF file
WGWeiwu Gao
Weiwu Gao
ZJZhengcai Jia
Zhengcai Jia
YTYi Tian
Yi Tian
PYPenghui Yang
Penghui Yang
HSHui Sun
Hui Sun
BNBing Ni
Bing Ni

23 October 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
SCShan Cui
Shan Cui
CWChenhui Wang
Chenhui Wang
WBWeizhi Bai
Weizhi Bai
JLJiao Li
Jiao Li
YPYue Pan
Yue Pan
YCYongwen Chen
Yongwen Chen
IGB3/CD1d1 determines the severity of DSS-colitis through inhibiting Nlrp3 , Il1b , and Il18 transcription in macrophages.

26 September 2025 in Cancer Research
Verified
Journal Article
Closed access
ZQZhong-Yi Qin
Zhong-Yi Qin
LCLin-Rong Che
Lin-Rong Che
STShuoran Tian
Shuoran Tian
XLXianfeng Li
Xianfeng Li
XDXiang-Yu Du
Xiang-Yu Du
BWBin Wang
Bin Wang
Tissue invasion is an initiating step of the cancer metastatic cascade. Unraveling the mechanisms underlying intracellular signaling pathway rewiring that activates downstream transcriptional machinery to drive invasiveness could help identify improved strategies to prevent and treat metastasis. Through an unbiased genome-wide CRISPR screen in a mouse model of gastric adenocarcinoma (GAC), an E3 ubiquitin ligase, tripartite motif–containing protein 49 (TRIM49), was identified as a potent suppressor of cancer invasiveness. In two thirds of GAC, TRIM49 expression was downregulated in invading cancer cells, in which TRIM49 deficiency correlated with deeper tumor infiltration and lymph node metastasis and was indicative of shorter overall patient survival. In multiple orthotopic GAC mouse models, TRIM49-deficient cancer cells were highly infiltrative, leading to multiorgan metastasis. Mechanistically, galectin-3, a putative regulator of cancer invasion, was stabilized in TRIM49-deficient cancer, largely because of the failure to undergo TRIM49-mediated polyubiquitination and proteasomal degradation. Consequently, galectin-3 assembled a complex with EGR1, thereby regulating transcriptional activities of a proinvasive gene module. As the galectin-3/EGR1 complex acted as a key node relaying proinvasive signaling, its disruption using GB1107, an oral galectin-3 inhibitor, suppressed tissue infiltration and metastasis of patient-derived xenografts. Taken together, a proinvasive galectin-3/EGR1 transcriptional complex was exploited by TRIM49-deficient GAC to fuel tissue invasion, representing an Achilles’ heel that is potentially targetable to prevent metastasis. Significance: A proinvasion galectin-3/EGR1 transcriptional complex is a therapeutic vulnerability in the highly invasive TRIM49-deficient gastric adenocarcinoma, which can be disrupted by the oral galectin-3 inhibitor GB1107 to prevent cancer spreading.

1 February 2018 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
QJQiong Jiang
Qiong Jiang
YLYao Liu
Yao Liu
BXBaoyan Xu
Baoyan Xu
WZWenhong Zheng
Wenhong Zheng
XXXiaomei Xiang
Xiaomei Xiang
YWYuzhang Wu
Yuzhang Wu

4 November 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
KJKe Jiang
Ke Jiang
QHQi He
Qi He
CWChenhui Wang
Chenhui Wang
WYWen Yang
Wen Yang
CZChangdong Zhou
Changdong Zhou
LGLiang Guo
Liang Guo
Background: The continuous clinical use of cisplatin is prevented by gastrointestinal toxicity. Methods: Cisplatin was used to treat THP-1-derived macrophages to see its differential effects on different subtypes of macrophages. Wild-type and Gsdme−/− mice models were used to examine the effect of cisplatin and metformin on intestinal inflammation in vivo. The effect of GSDME on macrophage polarization was further confirmed by GSDME knockdown. Results: We found that M2 macrophages, with more cell blebbing and GSDME cleavage, were more sensitive to cisplatin-induced pyroptosis than M1 macrophages. Cisplatin was capable of enhancing the M1 phenotype, which was reversed by GSDME knockdown. GSDME contributed to M1 polarization and GSDME knockdown promoted M2 phenotype via STAT6 activation. Reduced intestinal inflammation and increased M2 macrophage numbers was detected in cisplatin-treated GSDME-knockout mice. Furthermore, metformin alleviated cisplatin-induced intestinal inflammation by reducing M2 pyroptosis and enhancing M2 phenotype through GSDME inhibition. Conclusion: This is the first study to reveal the non-pyroptotic role of GSDME in macrophage polarization, revealing that metformin could be used in combination with cisplatin to reduce intestinal toxicity.